about
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studyRandomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer.Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.Radiosensitizers in cervical cancer. Cisplatin and beyond.Effects of base excision repair gene polymorphisms on pancreatic cancer survivalCell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and 212Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model.Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancerGemcitabine-mediated radiosensitization of human soft tissue sarcoma.A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma.Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a reviewThe role of neoadjuvant therapy in pancreatic cancer: a review.Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.Radiosensitization of Prostate Cancers In Vitro and In Vivo to Erbium-filtered Orthovoltage X-rays Using Actively Targeted Gold Nanoparticles.Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
P2860
Q24810507-6BF7725C-F729-4C61-AA25-385490178253Q33365043-8AEA54B7-D272-4275-92AA-82B66C20852DQ33389524-0976753E-4DFB-444D-88A6-E8DA7D652C70Q34183257-CE458081-BB76-457E-818F-CB1B33838B0EQ34369298-5069EDDA-9F16-4C63-BC9B-08F83DE23137Q34619179-FA7EFF4F-40C8-426C-93F8-77EFA9A2D03AQ34684307-2E7E8A36-E8D1-4E2C-A4DE-1276986BB8C7Q35842670-341CF8E1-A918-43AF-9263-1010CCE77B0CQ36088727-5BD7EE74-D808-4960-BDF8-FA3D7F2C5353Q36376503-0E857A3B-3AE1-465A-9C85-2F252FD3E331Q36831352-A03D4E24-222A-4456-BE06-5AB7204E56C5Q36916965-06202AA1-BB54-493A-9B38-61FCB0D91EFBQ36973610-8A8BDD6A-D2B3-4B29-AF1F-8DA253E51268Q37230970-0897C6BC-0CBF-4831-94AD-96799D015E0EQ38734981-6A059817-5430-4123-AB10-70C6868F7735Q39740700-AA07EA5D-875F-4EAE-A6CB-AF60899B4C1BQ42551562-6B531BAB-1A88-4581-8171-475432FBB030Q47101624-B6A8C970-9532-44E8-9695-AFF6B999B3BDQ47409321-213863AD-C520-4F2F-9B7E-E91CB4F9B73A
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Gemcitabine-mediated radiosensitization.
@en
type
label
Gemcitabine-mediated radiosensitization.
@en
prefLabel
Gemcitabine-mediated radiosensitization.
@en
P2093
P1433
P1476
Gemcitabine-mediated radiosensitization
@en
P2093
A Eisbruch
D S Shewach
T S Lawrence
P304
S7-24-S7-28
P433
P577
1997-04-01T00:00:00Z